(Q44551308)

4 December 2017

title

Linezolid clearance during continuous venovenous hemodiafiltration: a case report (English)

1 reference

4 December 2017

1 reference

1 reference

6

1 reference

4 December 2017

Michael D Kraft

1

1 reference

4 December 2017

Deborah A Pasko

2

1 reference

4 December 2017

Daryl D DePestel

3

1 reference

4 December 2017

Jessica J Ellis

4

1 reference

4 December 2017

Charles A Peloquin

5

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

4 December 2017

1 reference

4 December 2017

volume

23

1 reference

4 December 2017

issue

8

1 reference

4 December 2017

page(s)

1071-1075

1 reference

Antimicrobial resistance in intensive care units

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1071.32874

Methicillin-resistant Staphylococcus aureus infection in a renal allograft recipient treated successfully with a novel new antimicrobial agent (linezolid): new treatment options for infections due to resistant organisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1071.32874

Successful treatment of vertebral osteomyelitis with linezolid in a patient receiving hemodialysis and with persistent methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus bacteremias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1071.32874

Linezolid treatment of prosthetic hip Infections due to methicillin-resistant Staphylococcus aureus (MRSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1071.32874

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1071.32874

Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1071.32874

Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1071.32874

Current status of renal replacement therapy for acute renal failure. A survey of US nephrologists. The National Kidney Foundation Council on Dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1071.32874

A primer on continuous renal replacement therapy for critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1071.32874

Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1071.32874

Oxazolidinones: a new class of antibacterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1071.32874

Drug dosage in patients during continuous renal replacement therapy. Pharmacokinetic and therapeutic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1071.32874

Pharmacokinetics of continuous renal replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1071.32874

10.1592/PHCO.23.8.1071.32874

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference